CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the closing of its initial public offering of 12,176,471 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to 1,588,235 additional shares of common stock, at a public offering price of $17.00 per share. The aggregate gross proceeds to Beam Therapeutics from the offerin
IPO
via https://www.AiUpNow.com
February 11, 2020 at 07:46AM by , Khareem Sudlow
What is A.I. Up to Now?
Blogs For Gadget Lovers. Have A Great Business Idea And You're Ready To Build Your Future, But Don't Know Where To Start? Let AiUpNow Guide You.
Trending
-
#SeoTips Comcast is one of many corporations that regularly support small businesses through grants. The company’s RISE grant program is an...
-
#SeoTips The Overture Maps Foundation today launched the first beta of its global open map dataset. With this, the foundation, which is back...
-
#SeoTips Running a successful business is like planting a garden — it requires careful nurturing and attention to ensure that the roots of ...
